Shanrong Biotechnology Corp Stock Beta
| SRBT Stock | USD 0.32 0.33 50.77% |
Shanrong Biotechnology Corp fundamentals help investors to digest information that contributes to Shanrong Biotechnology's financial success or failures. It also enables traders to predict the movement of Shanrong Pink Sheet. The fundamental analysis module provides a way to measure Shanrong Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Shanrong Biotechnology pink sheet.
Shanrong |
Shanrong Biotechnology Corp Company Beta Analysis
Shanrong Biotechnology's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Shanrong Biotechnology Beta | -2.82 |
Most of Shanrong Biotechnology's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shanrong Biotechnology Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Shanrong Biotechnology Corp has a Beta of -2.8211. This is 444.04% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The beta for all United States stocks is notably higher than that of the company.
Shanrong Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Shanrong Biotechnology's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Shanrong Biotechnology could also be used in its relative valuation, which is a method of valuing Shanrong Biotechnology by comparing valuation metrics of similar companies.Shanrong Biotechnology is currently under evaluation in beta category among its peers.
As returns on the market increase, returns on owning Shanrong Biotechnology are expected to decrease by larger amounts. On the other hand, during market turmoil, Shanrong Biotechnology is expected to outperform it.
Shanrong Fundamentals
| Current Valuation | 914.35 K | |||
| Shares Outstanding | 380.98 K | |||
| Price To Sales | 0.52 X | |||
| Net Income | (31.75 K) | |||
| Cash And Equivalents | 30.87 K | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 2.22 M | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (31.75 K) | |||
| Earnings Per Share | (0) X | |||
| Beta | -2.82 | |||
| Market Capitalization | 380.98 K | |||
| Total Asset | 24.78 K | |||
| Net Asset | 24.78 K |
About Shanrong Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Shanrong Biotechnology Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shanrong Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shanrong Biotechnology Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Shanrong Pink Sheet Analysis
When running Shanrong Biotechnology's price analysis, check to measure Shanrong Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanrong Biotechnology is operating at the current time. Most of Shanrong Biotechnology's value examination focuses on studying past and present price action to predict the probability of Shanrong Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanrong Biotechnology's price. Additionally, you may evaluate how the addition of Shanrong Biotechnology to your portfolios can decrease your overall portfolio volatility.